Our finding of BC-associated autoreactivity of the non-coding region of the SPATA5 (Figure 3B; Table 1; Supplementary Table S1) suggests that this autoantibody may be a biomarker of BC risk as well as of SPATA5 dysregulation. The gene discussed is AFG2A; the disease is breast cancer.